Salarius Pharmaceuticals, Inc. (SLRX) .
이 페이지에서 입증된 기준:
SharesGrow 종합 점수: 46/100 2/7 개 기준 통과.
| Year | EPS (희석) | 매출 | 순이익 | 순이익률 |
|---|---|---|---|---|
| 2016 | $-12,150.00 | $1.01M | $-39.49M | -3907.6% |
| 2017 | $-9,950.00 | $1.27M | $-34.43M | -2701.7% |
| 2018 | $-6,100.00 | $838.14K | $-21.92M | -2615.6% |
| 2019 | $-424.00 | $3.47M | $-6.94M | -200.2% |
| 2020 | $-100.00 | $5.23M | $-7.35M | -140.5% |
| 2021 | $-62.00 | $1.84M | $-12.77M | -693.8% |
| 2022 | $-14.77 | $0.00 | $-31.37M | - |
| 2023 | $0.00 | $0.00 | $-12.54M | - |
| 2024 | $-5.79 | $0.00 | $-5.58M | - |
| 2025 | $-25.99 | $0.00 | $-12.52M | - |
